Cure51
Signal active
Organization
Contact Information
Overview
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
About
Industries
Software, Biotechnology, Database
Founded
2021
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Cure51 headquartered in Europe, operates in the Software, Biotechnology, Database sector. The company focuses on Software and has secured $196.9M in funding across 12 round(s). With a team of 11-50 employees, Cure51 is actively contributing to advancements in Software. Their latest funding round, Seed Round - Cure51, raised $16.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
5
Lead Investors
0
Total Funding Amount
$16.4M
Details
1
Cure51 has raised a total of $16.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed | 16.4M |
Investors
Cure51 is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Xavier Niel | - | FUNDING ROUND - Xavier Niel | 16.4M |
| Joanna Soroka | - | FUNDING ROUND - Joanna Soroka | 16.4M |
| Cure51 | - | FUNDING ROUND - Cure51 | 16.4M |
| Hitachi Ventures | - | FUNDING ROUND - Hitachi Ventures | 16.4M |
Recent Activity
There is no recent news or activity for this profile.